Nonopioid spinal analgesics: Animal experimentation and implications for clinical developments

Pain Reviews

Volumn 4, Issue 1, 1997, Pages 33-58

  Goodchild, Colin S ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANALGESIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; EXCITATORY AMINO ACID; FLUPIRTINE; GANGLIOSIDE; GLUTAMATE RECEPTOR ANTAGONIST; MORPHINE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE; TACHYKININ;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; DRUG TOLERANCE; GABAERGIC SYSTEM; NONHUMAN; REVIEW; SPINAL CORD;

EID: 0030920067     PISSN: 09681302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (248)

1. Cousins MJ, Mather LE. Intrathecal and epidural administration of opioids. Anesthesiology 1984; 61: 276-310.
2. Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics. Science 1976; 192: 1357-58.
3. Yaksh TL, Rudy TA. Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther 1977; 202: 411-28.
4. Alvarez FJ, Kavookjian AM, Light AR. Synaptic interactions between GABA-immunoreactive profiles and the terminals of functionally defined myelinated nociceptors in the monkey and cat spinal cord. J Neurosci 1992; 12: 2901-17.
5. Daval G, Verge D, Basbaum AI, Bourgoin S, Hamon M. Autoradiographic evidence of serotonin, binding sites on primary afferent fibres in the dorsal horn of the rat spinal cord. Neurosci Lett 1987; 83: 71-76.
6. 3H]serotonin arc presynaptic to enkephalin immunoreactive neurons in cat dorsal horn. Brain Res 1984; 298: 386-91.
7. Lovick T. The role of 5-HT, GABA and opioid peptides in presynaptic inhibition of tooth pulp input from the medial brainstem. Brain Res 1983; 289: 135-42.
8. Proudfit HK, Larson AA, Anderson EG. The role of GABA and serotonin in the mediation of rapheevoked spinal cord dorsal root potentials. Drain Res 1980; 195: 149-65.
9. Leah J, Cameron A, Snow P. Peptides in C and A-delta fibres of identified modality [Abstract]. Pain 1984; (suppl 2): S145.
10. Leah J, Menetrey D. Neuropeptides in propriospinal neurones in the rat. Brain Res 1989; 495: 173-77.
11. Archer T, Jonsson G, Minor BG, Post C. Noradrenergic-serotonergic interactions and nociception in the rat. Eur J Pharmacol 1986; 120: 295-307.
12. Kuraishi Y, Hirota N, Sato Y, Kaneko S, Satoh M, Takagi H. Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn. Brain Res 1985; 359: 177-82.
13. Lovick TA. Selective modulation of the cardiovascular response but not the antinociception evoked from the dorsal PAG, by 5-HT in the ventrolateral medulla. Pflugers Arch 1990; 416: 222-24.
14. Sawynok J. The 1988 Merck Frosst Award. The role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies. Can J Physiol Pharmacol 1989; 67: 975-88.
15. Hylden JLK, Wilcox GL. Intrathecal serotonin in mice: analgesia and inhibition of a spinal action of substance P. Life Sci 1983; 33: 789-95.
16. Hylden JLK, Wilcox GL. Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level. J Pharmacol Exp Ther 1983; 226: 398-404.
17. Hylden JLK, Wilcox GL. Antionciceptive action of intrathecal neurotensin in mice. Peptides 1983; 4: 517-20.
18. Goodchild CS, Serrao JM. Intrathecal midazolam in the rat: evidence for spinally-mediated analgesia. Br J Anaesth 1987; 59: 1563-70.
19. Butler SH, Godefroy F, Besson J-M, Weil-Fugazza J. A limited arthritic model for chronic pain studies in the rat. Pain 1992; 48: 73-81.
20. Castro-Lopes JM, Tavares I, Tolle TR, Coimbra A. Carrageenan-induced inflammation of the hind foot provokes a rise of GABA-immunoreactive cells in the rat spinal cord that is prevented by peripheral neuroectomy or neonatal capsaicin treatment. Pain 1994; 56: 183-201.
21. Hylden JLK, Nahin RL, Traub RJ, Dubner R. Expansion of receptive fields of spinal lamina I projection neurons in rats with unilateral adjuvant-induced inflammation: the contribution of dorsal horn mechanisms. Pain 1989; 37: 229-43.
22. Hylden JLK, Thomas DA, Iadarola MJ, Nahin RL, Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur J Pharmacol 1991; 194: 135-43.
23. Sluka KA, Westlund KN. An experimental arthritis model in rats: the effects of NMDA and non-NMDA antagonists on aspartate and glutamate release in the dorsal horn. Neitrosci Lett 1993; 149: 99-102.
24. Tjolsen A, Berge O-G, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992 51: 5-17.
25. Weil Fugazza J, Godefroy F, Coudert D, Besson JM. Total and free scrum tryptophan levels and brain 5-hydroxytryptamine metabolism in arthritic rats. Pain 1980; 9: 319-25.
26. Bennett GJ, Xie Y. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107.
27. Chung JM, Choi Y, Yoon YW, Na HS. Effects of age on behavioral signs of neuropathic pain in an experimental rat model. Neurosci Lett 1995; 183: 54-57.
28. Yoon YW, Na HS, Chung JM. Contributions of injured and intact afferents to neuropathic pain in an experimental rat model. Pain 1996; 64: 27-36.
29. Ahlgren SC, Levine JD. Mechanical hyperalgesia in streptozotocin-diabetic rats is not sympathetically maintained. Brain Res 1993; 606: 171-75.
30. Courteix C, Bardin M, Chantelauze C, Lavarenne J, Eschalier A. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain 1994; 57: 153-60.
31. Seybold VS, Hylden JL, Wilcox GL. Intrathecal substance P and somatostatin in rats: behaviors indicative of sensation. Peptides 1982; 3: 49-54.
32. Vaught JL, Post LJ, Jacoby HI, Wright D. Tachykinin-like central activity of neuromedin K in mice. Eur J Pharmacol 1984; 103: 355-57.
33. O'Donohue TL, Massari VJ, Pazoles CJ et al. A role for bombesin in sensory processing in the spinal cord. J Neurosci 1984; 4: 2956-62.
34. Willcockson WS, Chung JM, Hori Y, Lee KH, Willis WD. Effects of iontophoretically released peptides on primate spinothalamic tract cells. J Neurosci 1984; 4: 741-50.
35. Fleetwood-Walker SM, Mitchell R, Hope PJ, El-Yassir N, Molony V, Bladon CM. The involvement of neurokinin receptor subtypes in somatosensory processing in the superficial dorsal horn of the cat [published erratum appears in Brain Res 1992; 579: 357]. Brain Res 1990; 519: 169-82.
36. Cridland RA, Henry JL. Comparison of the effects of substance P, neurokinin A, physalaemin and eledoisin in facilitating a nociceptive reflex in the rat. Brain Res 1986; 381: 93-99.
37. Papir-Kricheli D, Gilon C, Chorev M, Selinger Z, Devor M. Neurochemical mediators of the behavioural effects of receptor-selective substance P agonists administered intrathecally in the rat. Neuropharmacology 1990; 29: 1055-65.
38. Duggan AW, Hendry IA, Morton CR, Hutchison WD, Zhao ZQ. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res 1988; 451: 261-73.
39. Duggan AW. Morton CR, Zhao ZQ, Hendry IA. Noxious heating of the skin releases immunoreactive substance P in the substantia gelatinosa of the cat: a study with antibody microprobes. Brain Res 1987; 403: 345-49.
40. Go VL, Yaksh TL. Release of substance P from the cat spinal cord. J Physiol (Lond) 1987; 391: 141-67.
41. Kuraishi Y, Hirota N, Sato Y, Hino Y, Satoh M, Takagi H. Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn. Brain Res 1985; 325: 294-98.
42. Piercey MF, Schroeder LA, Folkers K, Xu JC, Horig J. Sensory and motor functions of spinal cord substance P. Science 1981; 214: 1361-63.
43. Post C, Paulsson I. Antinociceptive and neurotoxic actions of substance P analogues in the rat's spinal cord after intrathecal administration. Neurosci Lett 1985; 57: 159-64.
44. Dougherty PM, Palecek J, Palecková V, Willis WD. Infusion of substance P or neurokinin A by microdialysis alters responses of primate spinothalamic tract neurons to cutaneous stimuli and to iontophoretically released excitatory amino acids. Pain 1995; 61: 411-25.
45. Battaglia G, Rustioni A. Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J Comp Neurol 1988; 277: 302-12.
46. Kellstein DE, Price DD, Hayes RL, Mayer DJ. Evidence that substance P selectively modulates C-fiber-evoked discharges of dorsal horn nociceptive neurons. Brain Res 1990; 526: 291-98.
47. Mendell LM. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol 1966; 16: 316-32.
48. Cook AJ, Woolf CJ, Wall PD, McMahon SB. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 1987; 325: 151-53.
49. Chapman V, Dickenson AH. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res 1992; 573: 321-23.
50. Aanonsen LM, Wilcox GL. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther 1987; 243: 9-19.
51. Kutsuwada T, Kashiwabuchi N, Mori H et al. Molecular diversity of the NMDA receptor channel. Nature 1992; 358: 36-41.
52. Monyer H, Sprengel R, Schoepfer R et al. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 1992; 256: 1217-21.
53. Urban L, Naeem S, Patel IA, Dray A. Tachykinin induced regulation of excitatory amino acid responses in the rat spinal cord in vitro. Neurosci Lett 1994; 168: 185-88.
54. Munglani R, Bond A, Smith GD et al. Changes in neuronal markers in a mononeuropathic rat model: relationship between neuropeptide Y, pre-emptive drug treatment and long-term mechanical hyperalgesia. Pain 1995 63: 21-31.
55. Collingridge GL, Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci 1990; 11: 290-96.
56. 2+ mobilization in rat cerebellar neurons. Eur J Pharmacol 1990; 186: 363-65.
57. Sommer B, Seeburg PH. Glutamate receptor channels: novel properties and new clones. Trends Pharmacol Sci 1992; 13: 291-96.
58. Schoepp DD, Conn PJ. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 1993; 14: 13-20.
59. Haley JE, Dickenson AH, Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992; 31: 251-58.
60. Haley JE, Wilcox GL, Chapman PF. The role of nitric oxide in hippocampal long-term potentiation. Neuron 1992; 8: 211-16.
61. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992; 356: 521-23.
62. Numann R, Catterall WA, Scheuer T. Functional modulation of brain sodium channels by protein kinase C phosphorylation. Science 1991; 254: 115-18.
63. Strong JA, Fox AP, Tsien RW, Kaczmarek LK. Stimulation of protein kinase C recruits covert calcium channels in Aplysiabag cell neurons. Nature 1919; 325: 714-17.
64. Wang LY, Dudek EM, Browning MD, MacDonald JF. Modulation of AMPA/kainate receptors in cultured murine hippocampal neurones by protein kinase C. J Physiol (Lond) 1994; 475: 431-37.
65. + channel required for modulation by protein kinase C. Science 1991; 254: 866-68.
66. Herdegen T, Kovary K, Leah J, Bravo R. Specific temporal and spatial distribution of JUN, FOS, and KROX-24 proteins in spinal neurons following noxious trans-synaptic stimulation. J Comp Neurol 1991; 313: 178-91.
67. Herdegen T, Tolle TR, Bravo R, Zieglgansberger W, Zimmerman M. Sequential expression of JUN B, JUN D and FOS P proteins in rat spinal neurons: cascade of transcriptional operations during nociception. Neurosci Lett 1991; 129: 221-24.
68. Zhu YS, Brodsky M, Franklin SO, Huang T, Inturrisi CE. Metrazole induces the sequential activation of c-fos, proenkephalin, and tyrosine-hydroxylase gene expression in the rat adrenal gland: modulation by glucocorticoid and adrenocorticotropic hormone. Mol Pharmacol 1993; 44: 328-35.
69. Abbadie C, Besson JM. Effects of morphine and naloxone on basal and evoked fos-like immunoreactivity in lumbar spinal cord neurons of arthritic rats. Pain 1993; 52: 29-39.
70. Abbadie C, Besson JM. Chronic treatments with aspirin or acetaminophen reduce both the development of polyarthritis and fos-like immunoreactivity in rat lumbar spinal cord. Pain 1994; 57: 45-54.
71. Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987; 328: 632-34.
72. Draisci G, Iadarola MJ. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Brain Res Mol Brain Res 1989; 6: 31-37.
73. Elliott KJ, Brodsky M, Hynansky AD, Foley KM., Inturrisi CE. Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA. Pain 1995; 61: 401-409.
74. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res 1992; 598: 271-78.
75. Mao J, Price DD, Mayer DJ, Lu J, Hayes RL. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res 1992; 576: 254-62.
76. Tal M, Bennett GJ. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat. Neurosci Lett 1993; 151: 107-10.
77. Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre- and post-treatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992; 77: 757-63.
78. Ben-Eliyahu S, Marek P, Vaccarino AL, Mogil JS, Sternberg WF, Liebeskind JC. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res 1992; 575: 304-308.
79. Marek P, Ben-Eliyahu S, Gold M, Liebeskind JC. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res 1991; 547: 77-81.
80. Marek P, Ben-Eliyahu S, Vaccarino AL, Liebeskind JC. Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res 1991; 558: 163-65.
81. Tanganelli S, Antonelli T, Morari M, Bianchi C, Beani L. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci Lett 1991; 122: 270-72.
82. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991; 251: 85-87.
83. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ, Frenk H. Intrathecal treatment with dextrorphan or ketamine potently reduced pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Res 1993; 605: 164-68.
84. Gutstein HB, Trujillo KA. MK-801 inhibits the development of morphine tolerance at spinal sites. Brain Res 1993; 626: 332-34.
85. Mao J, Price DD, Phillips LL, Lu J, Mayer DJ. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res 1995; 677: 257-67.
86. Mayer DJ, Mao J, Price DD. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 1995; 61: 365-74.
87. Sonni L, Cattaneo A, De Marco A, De Magnis A, Carli P, Marahini S. Idiopathic vulvodynia: clinical evaluation of the pain threshold with acetic acid solutions. J Reprod Med 1995; 40: 337-41.
88. Kolesnikov YA, Pick CG, Ciszewska G, Pasternak GW. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 1993; 90: 5162-66.
89. Carstens E, Tulloch I, Zieglgansberger W et al. Presynaptic excitability changes induced by morphine in single cutaneous afferent C- and A-fibres. Pflugers Arch 1979; 379: 143-47.
90. Chang HM, Berde CB, Holz GG, Steward GF, Kream RM. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50, 488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions. Anesthesiology 1989; 70: 672-77.
91. Gaumann DM, Yaksh TL, Tyce GM. Effects of sufentanil and naltrexone on adrenal vein catecholamines and neuropeptides during splanchnic nerve stimulation in cats. Synapse 1990; 6: 392-94.
92. Lombard MC, Besson JM. Attempts to gauge the relative importance of pre- and postsynaptic effects of morphine on the transmission of noxious messages in the dorsal horn of the rat spinal cord. Pain 1989; 37: 335-45.
93. Yaksh TL, Jessell TM, Gamse R, Mudge AW, Leeman SE. Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature 1980; 286: 155-57.
94. Chen L, Huang L-YM. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron 1991; 7: 319-26.
95. Daw NW, Stein PSG, Fox K. The role of NMDA receptors in information processing. Annu Rev Neurosci 1993; 16: 207-22.
96. Fox K, Daw NW. Do NMDA receptors have a critical function in visual cortical plasticity? Trends Neurosci 1993; 16: 116-22.
97. + channel. J Biol Chem 1994; 269: 7839-42.
98. Christie MJ, Williams JT, North RA. Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol Pharmacol 1987; 32: 633-38.
99. Harada H, Ueda H, Katada T, Ui M, Satoh M. Phosphorylated mu-opioid receptor purified from rat brains lacks functional coupling with Gil, a GTP-binding protein in reconstituted lipid vesicles. Neurosci Lett 1990; 113: 47-49.
100. Mestek A, Chen Y, Hurley JH et al. The μ opioid receptor: cellular function and tolerance development. Regul Pept 1994; 54: 193-94.
101. North RA, Williams JT, Surprenant A, Christie MJ. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 1987; 84: 5487-91.
102. Cahusac PM, Evans RH, Hill RG, Rodriquez RE, Smith DA. The behavioural effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology 1984; 23: 719-24.
103. Yaksh TL. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989; 37: 111-23.
104. Kristensen JD, Karlsten R, Gordh T, Berge O-G. The NMDA antgonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat. Pain 1994; 56: 59-67.
105. Kristensen JD, Svensson B, Gordh T. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 1992; 51: 249-53.
106. Auer RN, Coulter KC. The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801. Ada Neuropathol (Berl) 1994; 87: 1-7.
107. Fix AS, Long GG, Wozniak DF, Olney JW. Pathomorphologic effects of N-methyl-D-aspartate antagonists in the rat posterior cingulate/ retrosplenial cerebral cortex: a review. Drug Dev Res 1994; 32: 147-52.
108. Olney JW. Excitatory transmitter neurotoxicity. Neurobiol Aging 1994; 15: 259-60.
109. Olney JW. NMDA receptor hypofunction, excitotoxicity, and Alzheimer's disease. Neurobiol Aging 1995; 16: 459-61.
110. Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor - still lethal after eight years. Trends Neurosci 1995; 18: 57-58.
111. Wozniak DF, Brosnan-Watters G, Nardi A et al. MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning. Brain Res 1996; 707: 165-79.
112. McQuay HJ, Carroli D, Jadad AR et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design. Pain 1994; 59: 127-33.
113. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-57.
114. Stannard CF, Porter GE. Ketamine hydrochloride in the treatment of phantom limb pain. Pain 1993; 54: 227-30.
115. Mathisen LC, Skjelbred P, Skoglund LA, Oye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 1995; 61: 215-20.
116. Eide PK, Stubhaug A, Oye I, Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 1995; 61: 221-28.
117. Eide PK, Stubhaug A, Stenehjem AE. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery 1995; 37: 1080-87.
118. Persson J, Axelsson G, Hallin RG, Gustafsson LL. Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization. Pain 1995; 60: 217-22.
119. Ellison G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Rev 1995; 20: 250-67.
120. Eisenberg E, LaCross S, Strassman AM. The effects of the clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats. Eur J Pharmacol 1994; 255: 123-29.
121. Neugebauer V, Kornhuber J, Lucke T, Schaible HG. The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neurones. Neuro Report 1993; 4: 1259-62.
122. Zeltser R, Seltzer Z, Eisen A, Feigenbaum JJ, Mechoulam R. Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties. Pain 1991; 47: 95-103.
123. + levels in neuronal culture. Eur J Pharmacol 1992; 219: 53-57.
124. Lancaster JM, Davies JA. Desmethylimipramine potentiates NMDA responses in a mouse cortical slice preparation. Neuro Report 1991; 2: 665-68.
125. Mjellem N, Lund A, Hole K. Reduction of NMDA-induced behaviour after acute and chronic administration of desipramine in mice. Neuropharmacology 1993; 32: 591-95.
126. Watanabe Y, Saito H, Abe K. Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices. Neuropharmacology 1993; 32: 479-86.
127. Chabal C, Jacobson L, Mariano A, Chancy E, Britell CW. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 1992; 76: 513-17.
128. Devulder JE, Ghys L, Dhondt W, Rolly G. Neuropathic pain in a cancer patient responding to subcutaneously administered lignocaine. Clin J Pain 1993; 9: 220-23.
129. Edmondson EA, Simpson RK, Stubler DK, Beric A. Systemic lidocaine therapy for poststroke pain. South Med J 1993; 86: 1093-96.
130. Pfeifer MA, Ross DR, Schrage JP et al. A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care 1993; 16: 1103-15.
131. Jaffe RA, Rowe MA. Subanesthetic concentrations of lidocaine selectively inhibit a nociceptive response in the isolated rat spinal cord. Pain 1995; 60: 167-74.
132. Nagy I, Woolf CJ. Lignocaine selectively reduced C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics. Pain 1996; 64: 59-70.
133. Elliott K, Minami N, Kolesnikov YA, Pasternak GW, Inturrisi CE. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 1994; 56: 69-75.
134. Malmberg AB, Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 1993; 54: 291-300.
135. Triban C, Guidolin D, Fabris M et al. Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes 1989; 38: 1012-22.
136. Mao J, Hayes RL, Price DD, Coghill RC, Lu J, Mayor DJ. Post-injury treatment with GM1 ganglioside reduces nociceptive behaviors and spinal cord metabolic activity in rats with experimental peripheral mononeuropathy. Brain Res 1992; 584: 18-27.
137. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ. Intrathecal GM1 ganglioside and local nerve anesthesia reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res 1992; 584: 28-53.
138. Chaplan SR, Pogrel JW, Yaksh TL. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 1994; 269: 1117-23.
139. Gutlove DP, Brose WG, Luther RR, Bowersox SS. Use of intrathecal SNX-111, a novel analgesic, in the management of intractable brachial plexus avulsion pain [Abstract]. Pain 1997 (in press).
140. Jakovlev V, Sofia RD, Achterrath Tuckermann U, von Schlichtegroll A, Thiemer K. The pharmacologic effect of flupirtine, a structurally new analgesic. Arzneimittel Forschung 1985; 35: 30-43.
141. Nickel B, Herz A, Jakovlev V, Tibes U. Mechanism of action of the analgesic flupirtine. Arzneimittel Forschung 1985; 35: 1402-409.
142. 2-adrenergic mechanisms are involved in the depressent action of flupirtine on spinal reflexes in rats. Eur J Pharmacol 1995; 276: 247-55.
143. Lewis JW, Terman GW, Watkins LT, Mayor DJ, Liebeskind JC. Opioid and non-opioid mechanisms of footshock-induced analgesia: role of the spinal dorsolateral funiculus. Brain Res 1983; 267: 139-44.
144. Mayer DJ, Liebeskind JC. Pain reduction by focal electrical stimulation of the brain: an anatomical and behavioral analysis. Brain Res 1974; 68: 73-93.
145. Mayer DJ, Price DD. Central nervous systems mechanisms of analgesia. Pain 1976; 2: 379-404.
146. Reynolds DV. Surgery in the rat during electrical analgesia induced for focal brain stimulation. Science 1969; 164: 444-45.
147. Camarata PJ, Yaksh TL. Characterization of the spinal adrenergic receptors mediating the spinal effects produced by the microinjection of morphine into the periaqueductal gray. Brain Res 1985; 336: 133-42.
148. Hammond DL, Tyce GM, Yaksh TL. Efflux of 5-hydroxytryptamine and noradrenaline into spinal cord superfusates during stimulation of the rat medulla. J Physiol (Lond) 1985; 359: 151-62.
149. Kuraishi Y, Hirota N, Satoh M, Takagi H. Antinociceptive effects of intrathecal opioids, noradrenaline and serotonin in rats: mechanical and thermal algesic tests. Brain Res 1985; 326: 168-71.
150. Reddy SV, Maderdrut JL, Yaksh TL. Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther 1980; 213: 525-33.
151. Rcddy SV, Yaksh TL. Spinal noradrenergic terminal system mediates antinocicpetion. Brain Res 1980; 189: 391-401.
152. Xu X-J, Puke MJC, Wiesenfeld-Hallin Z. The depressive effect of intrathecal clonidine on the spinal flexor reflex is enhanced after sciatic nerve section in rats. Pain 1992; 51: 145-51.
153. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985; 22: 845-58.
154. Yaksh TL, Reddy SV. Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology 1981; 54: 451-67.
155. Fisher B, Zornow MH, Yaksh TL, Peterson BM. Antinociceptive properties of intrathecal dexmedetomidine in rats. Eur J Pharmacol 1991; 192: 221-25.
156. Sherman SE, Loomis CW, Milne B, Chervenko FW. Intrathecal oxymetazoline produces analgesia via spinal alpha-adrenoceptors and potentiates spinal morphine [published erratum appears in Eur J Pharmacol 1988; 154: 345-48]. Eur J Pharmacol 1988; 148: 371-80.
157. Davies J, Johnston SE. Selective antiociceptive effects of tizanidine (DS 103-282), a centrally acting muscle relaxant, on dorsal horn neurones in the feline spinal cord. Br J Pharmacol 1984; 82: 409-21.
158. Ishizuki M, Yanagisawa M. Antinociceptive effects of tizanidine, diazepam and eperisone in isolated spinal cord-tail preparations of newborn rat. Pain 1992; 48: 101-106.
159. Kroin JS, McCarthy RJ, Penn RD, Lubenow TR, Ivankovich AD. Intrathecal clonidine and tizanidine in conscious dogs: comparison of analgesic and hemodynamic effects. Anesth Analg 1996; 82: 627-35
160. Post C, Gordh T, Minor BG, Archer T, Freedman J. Antinociceptive effects and spinal cord tissue concentrations after intrathecal injection of guanfacine or clonidine into rats. Anesth Analg 1987; 66: 317-24.
161. 2-agonists, guanfacine and clonidine, in regard to duration of antinociception, and ventilatory and hemodynamic effects in goats. Anesth Analg 1992; 74: 712-18.
162. Malmberg AB, Yaksh TL. Pharmacology of the spinal action of ketorolac, morphine, ST-91 U50488H and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 1993; 79: 270-81.
163. Monasky MS, Zinsmeister AR, Stevens CW, Yaksh TL. Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance. J Pharmacol Exp Ther 1990; 254: 383-92.
164. Ruffolo RR, Hieble JP, Brooks DP, Feuerstein GZ, Nichols AJ. Drug receptors and control of the cardiovascular system: recent advances. Prog Drug Res 1991; 36: 117-360.
165. Ruffolo RR, Nichols AJ, Stadel JM, Hieble JP. Structure and function of alpha-adrenoceptors. Pharmacol Rev 1991; 43: 475-505.
166. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991; 74: 581-605.
167. Davis M, Commissaris RL, Yang S et al. Spinal vs. supraspinal sites of action of the alpha 2-adrenergic agonists clonidine and ST-91 on the acoustic startle reflex. Pharmacol Biochem Behav 1989; 33: 233-40.
168. Takano Y, Yaksh TL. Characterization of the pharmacology of intrathecally administered alpha-2-agonists and antagonists in rats. J Pharmacol Exp Ther 1992; 261: 764-72.
169. Takano Y, Yaksh TL. Chronic spinal infusion of dexmedetomidine, ST-91 and clonidine: spinal alpha 2 adrenoceptor subtypes and intrinsic activity. J Pharmacol Exp Ther 1993; 264: 327-35.
170. Ossipov MH, Harris S, Lloyd P, Messineo E, Lin B-S, Bagley J. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology 1990; 73: 1227-35.
171. Ossipov MH, Lozito R, Messineo E, Green J, Harris S, Lloyd P. Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: isobolographic analysis. Life Sci 1990; 47: PL71-PL76.
172. Ossipov MH, Suarez LJ, Spaulding TC. Antinociceptive interactions between alpha-2-adrenergic and opiate agonists at the spinal level in rodents. Anesth Analg 1989; 68: 194-200.
173. Aran S, Proudfit HK. Antinociception produced by interactions between intrathecally administered adenosine agonists and norepinephrine. Brain Res 1990; 513: 255-63.
174. Danzebrink RM, Gebhart GF. Intrathecal coadministration of clonidine with serotonin receptor agonists produces supra-additive visceral antinociception in the rat. Brain Res 1991; 555: 35-42.
175. Gordh T, Jansson I, Hartvig P, Gillberg PG, Post C. Interactions between noradrenergic and cholinergic mechanisms involved in spinal nociceptive processing. Ada Anaesthesiol Scand 1989; 33: 39-47.
176. Williams JS, Tong C, Eisenach JC. Neostigmine counteracts spinal clonidine-induced hypotension in sheep. Anesthesiology 1993; 78: 301-307.
177. b receptors to inhibition of peptide secretion from peripheral sensory neurons. J Neurosci 1989; 9: 657-66.
178. Ono H, Michima A, Ono S, Fukuda H, Vasko MR. Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by alpha-adrenergic receptor antagonists. Neuropharmacology 1991; 30: 585-89.
179. 2 agonists. Peptides 1993; 14: 371-78.
180. Eisenach JC, Grice SC. Epidural clonidine does not decrease blood pressure or spinal cord blood flow in awake sheep. Anesthesiology 1988; 68: 335-40.
181. Gordh T, Feuk U, Norlen K. Effect of epidural clonidine on spinal cord blood flow and regional and central hemodynamics in pigs. Anesth Analg 1986; 65: 1312-18.
182. Gordh T, Post C, Olsson Y. Evaluation of the toxicity of subarachnoid clonidine, guanfacine, and a substance P-antagonist on rat spinal cord and nerve roots: light and electron microscopic observations after chronic intrathecal administration. 1986; 65: 1303-11.
183. Gordh TE, Ekman S, Lagerstedt AS. Evaluation of possible spinal
184. Yaksh TL, Rathbun M, Jage J, Mirzai T, Grafe M, Hiles RA. Pharmacology and toxicology of chronically infused epidural clonidine•HCl in dogs. Fundamental Appl Toxicol 1994; 23: 319-35.
185. Carabine UA, Milligan KR, Moore J. Extradural clonidine and bupivacaine for postoperative analgesia. Br J Anaesth 1992; 68: 132-35.
186. Carabine UA, Milligan KR, Mulholland D, Moore J. Extradural clonidine infusions for analgesia after total hip replacement. Br J Anaesth 1992; 68: 338-43.
187. Filos KS, Goudas LC, Patroni O, Polyzou V. Intrathecal clonidine as a sole analgesic for pain relief after cesarean section. Anesthesiology 1992; 77: 267-74.
188. Filos KS, Goudas LC, Patroni O, Polyzou V. Hemodynamic and analgesic profile after intrathecal clonidine in humans: a dose-response study. Anesthesiology 1994; 81: 591-601.
189. Mogensen T, Eliasen K, Ejlersen E, Vegger P, Nielsen IK, Kehlet H. Epidural clonidine enhances postoperative analgesia from a combined low-dose epidural bupivacaine and morphine regimen. Anesth Analg 1992; 75: 607-10.
190. Motsch J, Gräber E, Ludwig K. Addition of clonidine enhances postoperative analgesia from epidural morphine: a double-blind study. Anesthesiology 1990; 73: 1067-73.
191. Rostaing S, Bonnet F, Levron JC, Vodinh J, Pluskwa F, Saada M. Effect of epidural clonidine on analgesia and pharmacokinetics of epidural fentanyl in postoperative patients. Anesthesiology 1991; 75: 420-25.
192. Eisenach JC, Rauck RL, Buzzanell C, Lysak SZ. Epidural clonidine analgesia for intractable cancer pain: phase I. Anesthesiology 1989; 71: 647-52.
193. Coventry DM, Todd G. Epidural clonidine in lower limb deafferentation pain [Letter]. Anesth Analg 1989; 69: 424-25.
194. Glynn C, Dawson D, Sanders R. A double-blind comparison between epidural morphine and epidural clonidine in patients with chronic non-cancer pain. Pain 1988; 34: 123-28.
195. Glynn CJ, Jamous MA, Teddy PJ, Moore RA, Lloyd JW. Role of spinal noradrenergic system in transmission of pain in patients with spinal cord injury. Lancet 1986; ii: 1249-50.
196. White DM, Kelleher K. Evidence that neuropeptide-induced increase in neurite outgrowth of rat sensory neurons is mediated via neurotrophin-3 [Abstract]. Pain 1997 (in press).
197. Cahill CM, White TD, Swaynok J. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes. J Pharmacol Exp Ther 1995; 275: 84-93.
198. Doak GJ, Sawynok J. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. Eur J Pharmacol 1995; 281: 311-18.
199. Poon A, Swaynok J. Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration. Eur J Pharmacol 1995; 286: 177-84.
200. Rattner DW, Castillo CFD, Warshaw AL. Pitfalls of distal pancreatectomy for relief of pain in chronic pancreatitis. Am J Surg 1996; 171: 142-45.
201. Sollevi A, Rane K, Segerdahl M, Goiny T, Lundeberg T. Intrathecal adenosine injection elevates cutaneous pain thresholds in man [Abstract]. Pain 1997 (in press).
202. Matsumura K, Watanabe Y, Imai-Matsumura K et al. Mapping of prostaglandin E2 binding sites in rat brain using quantitative autoradiography. Brain Res 1992; 581: 292-98.
203. Narumiya S, Ogorochi T, Nakao K, Hayaishi O. Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci 1982; 31: 2093-103.
204. Wolfe LS. Eicosanoids: prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J Neurochem 1982; 38: 1-14.
205. Braga PC. Ketoprofen: i.c.v. injection and electrophysiological aspects of antinociceptive effect. Eur J Pharmacol 1990; 184: 273-80.
206. Jurna I, Brune K. Central effect of the non-steroid anti-inflammatory agents, indomethacin, ibuprofen, and diclofenac, determined in C fibre-evoked activity in single neurones of the rat thalamus. Pain 1990; 41: 71-80.
207. Ramwell PW, Shaw JE, Jessup R. Spontaneous and evoked release of prostaglandins from frog spinal cord. Am J Physiol 1966; 211: 998-1004.
208. Ferreira SH, Lorenzetti BB, Correa FM. Blockade of central and peripheral generation of prostaglandins explains the antialgesic effect of aspirin-like drugs. Pol J Pharmacol Pharm 1978; 30: 133-40.
209. Ferreira SH, Lorenzetti BB, Correa FM. Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 1978; 53: 39-48.
210. 1 produces a long-lasting allodynic state. Pain 1995; 63: 303-11.
211. Taiwo YO, Levine JD. Prostaglandins inhibit endogeneous pain control mechanisms by blocking transmission at spinal noradrenergic synapses. J Neurosci 1988; 8: 1346-49.
212. Malmberg AB, Rafferty MF, Yaksh TL. Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test on the rat. Neurosci Lett 1994; 173: 193-96.
213. Malmberg AB, Yaksh TL. Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test. Eur J Pharmacol 1994; 256: 205-209.
214. 2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J Neurosci 1995; 15: 2768-76.
215. Schady W, Torebjork HE. Central effects of zomepirac on pain evoked by intraneural stimulation in man. J Clin Pharmacol 1984; 10: 429-35.
216. Bresink I, Danysz W, Parsons CG, Mutschler E. Different binding affinities of NMDA receptor channel blockers in various brain regions - indication of NMDA receptor heterogeneity. Neuropharmacology 1995; 34: 533-40.
217. Barnard EA, Bilbe G, Houamed K, Moss SJ, Van Renterghem C, Smart TG. Functional expression in the Xenopus oocyte of messenger ribonucleic acids encoding brain neurotransmitter receptors: further characterisation of the implanted GABA receptor. Neuropharmacology 1987; 26: 837-44.
218. Barnard EA, Seeburg PH. Structural basis of the GABA-activated chloride channel: molecular biology and molecular electrophysiology. Adv Biochem Psychopharmacol 1988; 45: 1-18.
219. 2L sub-units stably transfected into mouse fibroblast L-cells. Br J Pharmacol 1992; 107: 732-37.
220. A receptor α5 subunit [Abstract]. Biochem Soc Trans 1992; 20: 18S.
221. Edwards M, Serrao JM, Gent JP, Goodchild CS. On the mechanism by which midazolam causes spinally mediated analgesia. Anesthesiology 1990; 73 273-77.
222. Yanez A, Sabbe MB, Stevens CW, Yaksh TL. Interaction of midazolam and morphine in the spinal cord of the rat. Neuropharmacology 1990; 29: 359-64.
223. Borg PA, Krijnen HJ. Long-term intrathecal administration of midazolam and clonidine. Clin J Pain 1996; 12: 63-68.
224. De Jong RH. Neuropathic pain may not respond to sympathetic blockade. Anesth Analg 1990; 71: 314.
225. Serrao JM, Marks RL, Morley SJ, Goodchild CS. Intrathecal midazolam for the treatment of chronic mechanical low back pain: a controlled comparison with epidural steroid in a pilot study. Pain 1992; 48: 5-12.
226. Schoeffler P, Auroy P, Bazin JE, Taxi J, Woda A. Subarachnoid midazolam: histologic study in rats and report of its effect on chronic pain in humans. Reg Anesth 1991; 16: 329-32.
227. Svensson BA, Welin M, Gordh T, Westman J. Chronic subarachnoid midazolam (Dormicum) in the rat. Morphologic evidence of spinal cord neurotoxicity. Reg Anesth 1995; 20: 426-34.
228. Madsen JB, Jensen FM, Crawford ME, Toftdahl DB. Catheterization of the epidural space in the rabbit. Neuropathological effects of epidural meptazinol and midazolam [Abstract]. Pain 1990; (suppl 5): S124.
229. Serrao JM, Mackenzie JM, Goodchild CS, Gent JP. Intrathecal midazolam in the rat: an investigation of possible neurotoxic effects. Eur J Anaesthesiol 1990; 7: 115-22.
230. Waldmeier PC, Wicki P, Feldtrauer JJ, Baumann PA. Potential involvement of a baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro. Naunyn Schmiedebergs Arch Pharmacol 1988; 337: 289-95.
231. Guo Z, Gent JP, Goodchild CS. Two GABA mechanisms for spinally-mediated antinociception: evidence from antagonism of 5-hydroxytryptamine (5HT) by bicuculline [Abstract]. Br J Anaesth 1990; 64: 589P-90P.
232. a receptors and spinally-mediated antinociception in rats. J Pharmacol Exp Ther 1996; 278: 620-26.
233. Nadeson R, Goodchild CS. Non-sedating doses of propofol produce antinociception by the same spinal mechanism responsible for intrathecal midazolam antinociception [Abstract]. Pain 1997 (in press).
234. Saade NE, Tabet MS, Banna NR, Atweh SF, Jabbur SJ. Inhibition of nociceptive evoked activity in spinal neurons through a dorsal column-brainstem-spinal loop. Brain Res 1985; 339: 115-18.
235. Kangrga I, Jiang MC, Randic M. Actions of (-)-baclofen on rat dorsal horn neurons. Brain Res 1991; 562: 265-75.
236. B receptor. J Pharmacol Exp Ther 1993; 265: 765-70.
237. B receptors. Trends Pharmacol Sci 1993; 14: 259-61.
238. Ashton D, Willems R. In vitro studies on the broad spectrum anticonvulsant loreclezole in the hippocampus. Epilepsy Res 1992; 11: 75-88.
239. Bazemore AW, Elliott KAC, Florey E. Isolation of factor I. J Neurochem 1957; 1: 334-39.
240. Florey E. An inhibitory and excitatory effect: extracts of mammalian central nervous system and their action on a single sensory neuron. Arch Int Physiol 1954; 62: 33-53.
241. Galindo A. Effects of procaine pentobarbitol and halothane on synaptic transmission in the central nervous system. J Pharmacol Exp Ther 1969; 169: 185-95.
242. Sawynok J. GABA-ergic mechanisms in antinociception. Prog Neuropsychopharmacol Biol Psychiatry 1984; 8: 581-86.
243. Tokuyama S, Takahashi M, Kaneto H. Participation of GABA-ergic systems in the production of antinociception by various stresses in mice. Jpn J Pharmacol 1992; 60: 105-10.
244. Wesselman JPM, Van Wilgenburg H, Long SK. The effects of pentobarbital and benzodiazepines on GABA-responses in the periphery and spinal cord in vitro. Neurosci Lett 1991; 128: 261-64.
245. b receptors in nociception induced by formalin in the rat [Abstract]. Pain 1997 (in press).
246. a receptors in the spinal cord limits the second, but not the first phase response to formalin in the rat [Abstract]. Pain 1997 (in press).
247. Ralston DD, Meng X, Behbehani M, Sehlhorst SC, Ralston HJ. Changes in GABA-ergic circuitry in rat dorsal horn neurons in response to partial constriction of the sciatic nerve: a light and electron microscopic study [Abstract]. Pain 1997 (in press).
248. B receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy. Brain Res 1995; 679: 289-97.